Naturally acquired microchimerism has recently been investigated in autoimmune diseases, including scleroderma, thyroiditis, primary biliary cirrhosis, Sjogren syndrome, systemic lupus ...

Ipsen has been given accelerated approval by the FDA for Iqirvo, which becomes the first dual PPAR alpha/delta agonist for rare cholestatic liver disease primary biliary cholangitis (PBC).

Scleroderma is classified as a rare, autoimmune, collagen-vascular disease of unknown etiology that can be difficult to diagnose and treat. Its onset can be insidious or rapid; the symptoms range ...

Weight-Loss Surgery Lowers Risk of Developing Complications of Liver Disease in Patients With Cirrhosis and Obesity Jan. 27, 2025 — A study shows that patients with obesity and fatty liver ...

In multiple sclerosis (MS), a person's immune system attacks the protective covering (myelin sheath) of nerve fibers in the brain and spinal cord (central nervous system). MS disease-modifying ...

This study aimed to employ a global antibody profiling strategy to identify novel antibodies and investigate their association with systemic sclerosis (SSc). Methods We implemented this strategy by ...

Medications are the mainstay of treatment for multiple sclerosis (MS). Many of them are used to block the immune system's ... Ocrelizumab is an infusion medication that treats CIS, relapsing-remitting ...

a US-based biotechnology company, announced U.S. FDA approval for Ocrevus Zunovo ocrelizumab & hyaluronidase-ocsq to treat both relapsing multiple sclerosis RMS and primary progressive multiple ...

You will be able to get a quick price and instant permission to reuse the content in many different ways. In most cases, the diagnosis of multiple sclerosis (MS) presents few difficulties. Clinical ...

Identifying the seven continents, five oceans, the Equator, the Northern and Southern Hemisphere and the North and South Pole. and The Arctic Ocean. I orbit around the sun. Not that fast! It ...

41 St. Joseph's Health Care London and University of Western Ontario, London, Ontario, Canada Objective The 1980 American College of Rheumatology (ACR) classification criteria for systemic sclerosis ...